Malignant Female Reproductive System Neoplasm

Malignant Female Reproductive System Neoplasm — Trials · CancerIndex

Clinical trials

Registered studies

6,253 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 1,463
Recruiting: 820
Ph III recruiting: 96
Growth YoY: +6.3%
Industry share: 26%
Top sponsor: National Cancer Institute (NCI)
Termination share: 28.3%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (740)

clinicaltrialsPublishedShowing 101–150 of 6,253 studies · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT00515372	Depression Treatment and Screening in Ovarian Cancer Patients	active not recruiting	Phase 1	409	M.D. Anderson Cancer CenterOTHER	1	Sep 18, 2026	clinicaltrials
NCT03943316	Prospective Laboratory Study Biologic Specimens and Tumor Tissue of Patients With Cancer	recruiting	—	500	New Mexico Cancer Research AllianceOTHER	1	Sep 18, 2026	clinicaltrials